Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

Pathophysiology, classification, and complications of common asymptomatic thrombocytosis in newborn infants

  • Jeon, Ga Won (Department of Pediatrics, Inha University Hospital, Inha University College of Medicine)
  • 투고 : 2021.07.01
  • 심사 : 2021.09.25
  • 발행 : 2022.04.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

We frequently encounter newborn infants with thrombocytosis in the neonatal intensive care unit. However, neonatal thrombocytosis is not yet fully understood. Thrombocytosis is more frequently identified in newborns and young infants, notably more often in those younger than 2 years than in older children or adults. The production of megakaryocytes (megakaryopoiesis) and platelets (thrombopoiesis) is mainly regulated by thrombopoietin (TPO). Increased TPO levels during infection or inflammation can stimulate megakaryopoiesis, resulting in thrombopoiesis. TPO concentrations are higher in newborn infants than in adults. Levels increase after birth, peak on the second day after birth, and start decreasing at 1 month of age. Initial platelet counts at birth increase with gestational age. Thus, preterm infants have lower initial platelet counts at birth than late-preterm or term infants. Postnatal thrombocytosis is more frequently observed in preterm infants than in term infants. A high TPO concentration and low TPO receptor expression on platelets leading to elevated plasma-free TPO, increased sensitivity of megakaryocyte precursor cells to TPO, a decreased red blood cell count, and immaturity of platelet regulation are speculated to induce thrombocytosis in preterm infants. Thrombocytosis in newborn infants is considered a reactive process (secondary thrombocytosis) following infection, acute/chronic inflammation, or anemia. Thrombocytosis in newborn infants is benign, resolves spontaneously, and, unlike in adults, is rarely associated with hemorrhagic and thromboembolic complications.

키워드

참고문헌

  1. Jensen MK, de Nully Brown P, Nielsen OJ, Hasselbalch HC. Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area. Eur J Haematol 2000;65:132-9. https://doi.org/10.1034/j.1600-0609.2000.90236.x
  2. Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol 2005;129:165-77. https://doi.org/10.1111/j.1365-2141.2004.05329.x
  3. Matsubara K, Baba K, Nigami H, Harigaya H, Ishiguro A, Kato T, et al. Early elevation of serum thrombopoietin levels and subsequent thrombocytosis in healthy preterm infants. Br J Haematol 2001;115:963-8. https://doi.org/10.1046/j.1365-2141.2001.03183.x
  4. Del Rey Hurtado de Mendoza B, Esponera CB, Izquierdo Renau M, Iglesias Platas I. Asymptomatic late thrombocytosis is a common finding in very preterm infants even in the absence of erythropoietin treatment. J https://doi.org/10.1177/0300060518821033
  5. Ozcan C, Sayli TR, Kosan-Culha V. Reactive thrombocytosis in children. Turk J Pediatr 2013;55:411-6.
  6. Davenport P, Liu ZJ, Sola-Visner M. Changes in megakaryopoiesis over ontogeny and their implications in health and disease. Platelets 2020;31:692-9. https://doi.org/10.1080/09537104.2020.1742879
  7. Margraf A, Zarbock A. Platelets in inflammation and resolution. J Immunol 2019;203:2357-67. https://doi.org/10.4049/jimmunol.1900899
  8. Ishiguro A, Suzuki Y, Mito M, Shimbo T, Matsubara K, Kato T, et al. Elevation of serum thrombopoietin precedes thrombocytosis in acute infections. Br J Haematol 2002;116:612-8. https://doi.org/10.1046/j.0007-1048.2001.03304.x
  9. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006;4:445-57. https://doi.org/10.1038/nrmicro1425
  10. Sola-Visner M, Sallmon H, Brown R. New insights into the mechanisms of nonimmune thrombocytopenia in neonates. Semin Perinatol 2009;33:43-51. https://doi.org/10.1053/j.semperi.2008.10.008
  11. Wiedmeier SE, Henry E, Sola-Visner MC, Christensen RD. Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol 2009;29:130-6. https://doi.org/10.1038/jp.2008.141
  12. Nakayama H, Ihara K, Hikino S, Yamamoto J, Nagatomo T, Takemoto M, et al. Thrombocytosis in preterm infants: a possible involvement of thrombopoietin receptor gene expression. J Mol Med (Berl) 2005;83:316-20. https://doi.org/10.1007/s00109-004-0619-z
  13. Ishiguro A, Nakahata T, Matsubara K, Hayashi Y, Kato T, Suzuki Y, et al. Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels. Br J Haematol 1999;106:884-8. https://doi.org/10.1046/j.1365-2141.1999.01641.x
  14. Maruyama H, Nakamura M, Yonemoto N, Kageyama M. Thrombocytopenia at birth is a predictor of cholestasis in infants with small for gestational age. Acta Med Okayama 2013;67:219-25.
  15. Amarilyo G, Oren A, Mimouni FB, Ochshorn Y, Deutsch V, Mandel D. Increased cord serum inflammatory markers in small-for-gestational-age neonates. J Perinatol 2011;31:30-2. https://doi.org/10.1038/jp.2010.53
  16. Wasiluk A, Mantur M, Kemona H, Szczepanski M, Jasinska E, Milewski R. Thrombopoiesis in small for gestational age newborns. Platelets 2009;20:520-4. https://doi.org/10.3109/09537100903207505
  17. Gutti U, Pasupuleti SR, Sahu I, Kotipalli A, Undi RB, Kandi R, et al. Erythropoietin and thrombopoietin mimetics: Natural alternatives to erythrocyte and platelet disorders. Crit Rev Oncol Hematol 2016;108:175-86. https://doi.org/10.1016/j.critrevonc.2016.11.002
  18. Gurney AL, Kuang WJ, Xie MH, Malloy BE, Eaton DL, de Sauvage FJ. Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood 1995;85:981-8. https://doi.org/10.1182/blood.v85.4.981.bloodjournal854981
  19. Yadav D, Chandra J, Sharma S, Singh V. Clinicohematological study of thrombocytosis. Indian J Pediatr 2010;77:643-7. https://doi.org/10.1007/s12098-010-0091-4
  20. McPherson RJ, Juul S. Patterns of thrombocytosis and thrombocytopenia in hospitalized neonates. J Perinatol 2005;25:166-72. https://doi.org/10.1038/sj.jp.7211230
  21. Haiden N, Cardona F, Schwindt J, Berger A, Kuhle S, Homoncik M, et al. Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity. Thromb Haemost 2005;93:118-23. https://doi.org/10.1160/TH04-02-0093
  22. Stohlawetz PJ, Dzirlo L, Hergovich N, Lackner E, Mensik C, Eichler HG, et al. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 2000;95:2983-9. https://doi.org/10.1182/blood.v95.9.2983.009k27_2983_2989
  23. Garraud O, Hamzeh-Cognasse H, Pozzetto B, Cavaillon JM, Cognasse F. Bench-to-bedside review: platelets and active immune functions - new clues for immunopathology? Crit Care 2013;17:236. https://doi.org/10.1186/cc12716
  24. Thom CS, Echevarria E, Osborne AD, Carr L, Rubey KM, Salazar E, et al. Extreme thrombocytosis is associated with critical illness and young age, but not increased thrombotic risk, in hospitalized pediatric patients. J Thromb Haemost 2020;18:3352-8. https://doi.org/10.1111/jth.15103
  25. Sutor AH. Thrombocytosis in childhood. Semin Thromb Hemost 1995;21:330-9. https://doi.org/10.1055/s-2007-1000654
  26. Wiedmeier SE, Henry E, Burnett J, Anderson T, Christensen RD. Thrombocytosis in neonates and young infants: a report of 25 patients with platelet counts of > or = 1000000 microl(-1.. J Perinatol 2010;30:222-6. https://doi.org/10.1038/jp.2009.146
  27. Lee JM, Lee H, Eom KS, Lee SE, Kim M, Kim Y. Impact of integrated genetic information on diagnosis and prognostication for myeloproliferative neoplasms in the next-generation sequencing era. J Clin Med 2021;10:1033. https://doi.org/10.3390/jcm10051033
  28. Denton A, Davis P. Extreme thrombocytosis in admissions to paediatric intensive care: no requirement for treatment. Arch Dis Child 2007;92:515-6. https://doi.org/10.1136/adc.2006.111484
  29. Christensen RD, Henry E, Del Vecchio A. Thrombocytosis and thrombocytopenia in the NICU: incidence, mechanisms and treatments. J Matern Fetal Neonatal Med 2012;25 Suppl 4:15-7.
  30. Salter L, Offiah AC, Bishop N. Elevated platelet counts in a cohort of children with moderate-severe osteogenesis imperfecta suggest that inflammation is present. Arch Dis Child 2018;103:767-71. https://doi.org/10.1136/archdischild-2017-313859
  31. Brousse V, Buffet P, Rees D. The spleen and sickle cell disease: the sick(led. spleen. Br J Haematol 2014;166:165-76. https://doi.org/10.1111/bjh.12950
  32. Albert TS, Meng YG, Simms P, Cohen RL, Phibbs RH. Thrombopoietin in the thrombocytopenic term and preterm newborn. Pediatrics 2000;105:1286-91. https://doi.org/10.1542/peds.105.6.1286
  33. Lim Y, Lee JO, Bang SM. Incidence, survival and prevalence statistics of classical myeloproliferative neoplasm in Korea. J Korean Med Sci 2016;31:1579-85. https://doi.org/10.3346/jkms.2016.31.10.1579
  34. Vinekar A, Hegde K, Gilbert C, Braganza S, Pradeep M, Shetty R, et al. Do platelets have a role in the pathogenesis of aggressive posterior retinopathy of prematurity? Retina 2010;30:S20-3.